近一年中国3D打印机出口情况统计图 数据来源：中国海关，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 相关报告：智研咨询发布的《2025-2031年中国3D打印机行业市场全景调研及投资前景研判报告》 根据中国海关数据显示：2025年7月中国3D打印机出口数量为36万台，同比增长32.1%，出口金额为 1.16亿美元，同比增长12.6%。 ...

本次固定资产投资将进一步扩大南方增材3D打印服务业务的生产规模，提高南方增材订单的承接和交 付能力，有利于持续构筑并强化南方增材的竞争优势，符合公司长远发展规划。 南风股份(300004.SZ)发布公告，根据全资子公司南方增材科技有限公司(以下简称"南方增材")发展战略 规划，为抓住3D打印行业快速发展的机遇，扩大生产规模以满足市场及客户需求，南方增材拟投资 5000万元用于3D打印服务项目固定资产投资。 ...

Core Viewpoint - The company Nanfeng Co., Ltd. plans to invest 50 million yuan in fixed assets for a 3D printing service project to capitalize on the rapid growth of the 3D printing industry and expand production capacity to meet market and customer demands [1] Group 1 - The investment aims to enhance the production scale of Nanfeng's subsidiary, Nanfang Additive Technology Co., Ltd., in the 3D printing service sector [1] - This fixed asset investment will improve Nanfang Additive's order acceptance and delivery capabilities, thereby strengthening its competitive advantage [1] - The initiative aligns with the company's long-term development strategy [1]

Group 1 - The core viewpoint of the article is that Nanfeng Co., Ltd. plans to invest 50 million yuan in fixed asset investment for a 3D printing service project to capitalize on the rapid growth of the 3D printing industry [1] Group 2 - Nanfeng Co., Ltd. aims to expand production capacity to meet market and customer demands through this investment [1]

Core Viewpoint - The company, Nanfeng Co., announced that its wholly-owned subsidiary, Nanfang Additive Technology Co., plans to invest 50 million yuan in fixed asset investment for a 3D printing service project, aimed at enhancing production capacity and order fulfillment capabilities [1] Investment Details - The investment will be used to purchase new 3D printing equipment, which will increase the production scale of Nanfang Additive's 3D printing services [1] - The project will be located in Foshan, Guangdong Province, and the funding will come from self-raised capital [1] Strategic Alignment - This investment aligns with the company's long-term development plan, indicating a commitment to expanding its 3D printing service capabilities [1] - The expected impact on the company's operating performance for the year 2025 is not anticipated to be significant [1]

Core Insights - Dongguan Zhaowu 3D Printing Co., Ltd. has been established with a registered capital of 100,000 RMB [1] - The company operates in various sectors including 3D printing services, sales of 3D printing materials, and manufacturing of additive manufacturing equipment [1] Company Overview - The registered capital of Dongguan Zhaowu 3D Printing Co., Ltd. is 100,000 RMB [1] - The company’s business scope includes general projects such as 3D printing services, sales of basic materials for 3D printing, and manufacturing of additive manufacturing equipment [1] - Additional services offered include laser marking processing, mechanical parts processing, and furniture accessory production [1] Industry Activities - The company is involved in the sales and manufacturing of various products including rubber products, electronic devices, and power electronic components [1] - It also engages in new material technology research and development, as well as technology consulting and services [1] - The company provides industrial design services, information system integration services, and advertising design and production [1]

（原标题：3D打印助力肺癌治疗"新突破"！今年已注册相关企业3.26万家） 企查查数据显示，从经营时间来看，近六成3D打印相关企业成立于近三年，其中成立年限在1-3年的相 关企业最多，占比34.71%。成立年限在1年内的相关企业占比24.71%。 3D打印（3DP）又称增材制造技术，是一种依据三维CAD数据通过逐层材料累加的方法制造实体零件 的技术。目前在珠宝设计、工业设计、建筑设计、工程设计与施工、汽车设计与制造等设计与制造领 域，以及航空航天、牙科等医疗领域都有所应用。 3.分布在新一线城市的相关企业最多 据媒体报道，近日，浙江大学医学院附属第四医院/浙江省肺癌精准诊疗重点实验室主任王凯教授团队 在国际顶级材料科学期刊《AdvancedMaterials》在线发表研究论文《一种协同作用的3D打印套环将射 频消融转化为有效的肺癌热免疫疗法》创新性提出解决方案。其研究设计的"3D打印项圈"可以成功地 提高肺癌治疗的整体效果，为提升肺癌治疗效果、降低复发风险提供了全新治疗策略。 企查查数据显示，从城市线级分布来看，分布在新一线城市的3D打印相关企业最多，占比26.17%。其 次，分布在一线城市、二线城市的相关企 ...

Group 1 - The establishment of Dushan Printing Technology (Jiangsu) Co., Ltd. has been recently reported, with a registered capital of 10 million RMB [1] - The legal representative of the company is Xu Chunhong [1] - The company's business scope includes technology services, development, consulting, and various sales related to 3D printing and casting materials [1] Group 2 - The company is involved in the sales and manufacturing of molds, mechanical parts, and general equipment [1] - It also engages in the import and export of goods, excluding projects that require approval [1] - The company aims to operate independently under its business license [1]

Summary of the Conference Call on Consumer-Level 3D Printing Industry Overview - The consumer-level 3D printing industry in China is experiencing strong export growth, with exports to the US accounting for 37% and Germany for 20% in the first half of 2024. The total export volume for the year is projected to reach 3.77 million units, generating revenue of 8.2 billion RMB, a year-on-year increase of 33% [1][5]. - The global market size for consumer-level 3D printing reached $19.8 billion in 2024, with an expected annual growth rate of 18.6% over the next 5 to 6 years [2]. Key Players - **拓竹科技 (Tao Zhu Technology)**: - Became the industry leader within three years by continuously iterating new models, building overseas brand presence, and creating a user co-creation community called Make World, which has over 1 million registered users [1][6]. - Reported revenue of 2.7 billion RMB in 2023, with a projected revenue exceeding 5.5 billion RMB and a net profit nearing 2 billion RMB in 2024 [3][9]. - **创想 3D (Chuangxiang 3D)**: - The second-largest consumer-level printer supplier globally and the largest consumer-level scanner supplier, currently pursuing an IPO in Hong Kong to expand market share [7]. Market Dynamics - The consumer-level 3D printing market is characterized by a shift towards professional applications, with B-end demand accounting for 60% and C-end demand for 40% [1][2]. - The industry benefits from improvements in equipment usability, speed, precision, yield, and cost reductions. For instance, the entry-level product price of Tao Zhu Technology dropped from 3,700 RMB in 2022 to 1,500 RMB in 2024 [4]. Growth Factors - Internal factors driving growth include advancements in technology (AI applications for real-time diagnostics and model generation) and significant cost reductions in both equipment and materials [4]. - External factors include the diversification of application scenarios, such as dental crowns in healthcare, small-batch figurines in cultural creativity, and jewelry supports in the jewelry industry [4]. Competitive Landscape - Domestic brands like Tao Zhu Technology and Chuangxiang 3D are rapidly increasing their global influence, surpassing established brands like Prusa in search volume on platforms like Google and Amazon [3][8]. - Tao Zhu Technology has maintained a market share exceeding 50% for five consecutive quarters, with a projected sales growth of 627% for the 2025 618 sales event [9]. Investment Opportunities - The upstream supply chain presents opportunities in consumables, particularly PLA materials, which are widely used and have strong repurchase attributes [13]. - Key components in the midstream supply chain include laser modules, motors, and scanners, with companies like 海正生材 (Haizheng Biomaterials) and 嘉联科技 (Jialian Technology) showing potential in PLA production [14][15][16]. Conclusion - The consumer-level 3D printing industry is poised for significant growth, driven by technological advancements, cost reductions, and expanding application scenarios. Domestic players are increasingly competitive on a global scale, presenting various investment opportunities across the supply chain.

Group 1 - The first national 3D printing drug production license has been issued in Nanjing, marking a significant step in the development and industrialization of 3D printing technology in pharmaceuticals [2] - The licensed entity, Nanjing SanDieJi Pharmaceutical Technology Co., has a production capacity of 300 million 3D printed drug pieces annually, making it the largest commercial production base for 3D printed drugs globally [2] - 3D printing technology offers advantages over traditional pharmaceutical manufacturing, including complex drug structure design, digital drug development, precise drug delivery, and intelligent manufacturing [2] Group 2 - The 3D printing market in China is projected to reach approximately 423 billion yuan in 2024 and is expected to exceed 450 billion yuan by 2025, driven by the increasing application of 3D printing products and the release of pent-up demand for 3D printing equipment [3] - The application fields of 3D printing are expanding, covering industries such as aerospace, automotive, biomedical, construction, and consumer goods, with rapid growth in the consumer electronics sector [3] Group 3 - Seven 3D printing concept stocks have been frequently researched by institutions, with notable companies including Dazong Laser, Aobi Zhongguang-UW, and Yuedan New Materials, among others [5] - The average increase in the stock prices of 3D printing concept stocks this year is 37.05%, with Zhongzhou Special Materials leading with a 192% increase [5][6] - Companies like Aidi Te and Huazhu High-Tech are actively involved in the 3D printing sector, with Aidi Te having launched multiple 3D printers and Huazhu High-Tech developing its own 3D printing equipment and materials [4][5] Group 4 - Xie Chuang Data (300857) has seen its stock price rise significantly, reaching a market value of 44.303 billion yuan, with a maximum increase of over 11 times compared to its three-year low [7] - The company reported a revenue of 4.944 billion yuan in the first half of the year, a year-on-year increase of 38.18%, with a net profit of 432 million yuan, reflecting a growth of 20.76% [7]